Topic 1: Basic Information Flashcards

1
Q

When do you measure baseline characteristics

A

Prior to randomisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When do you compare outcomes from

A

Point of randomisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why do you take baseline characteristics

A

To compare the characteristics of patients in your trial to the characteristics of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does baseline data tell you

A

Who you can generalise the results to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a subgroup effect

A

The effect of certain characteristics that can be used to predict outcomes, given a prognostic model and can therefore be predictors of the size of treatment effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is often looked at in exploratory analysis

A

Subgroup effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Common exclusions of patients

A

Learning difficulties, elderly, frail, pregnant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How many primary research questions are there usually

A

One

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does PICOTC stand for

A

Population, Intervention, Control, Outcome, Timing and Context

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Is the design and cost of the trial dictated by the primary or secondary research question

A

Primary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Secondary Questions are regarded as exploratory, true or false

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the PICOTC framework used for

A

Designing Research questions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Examples of Secondary Objectives

A

Adverse effects, withdrawals, quality of life, subgroup effects, what baseline factors predict a reduction in score etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens in Phase 1 Trial

A

Look at if drug is harmful to humans, uses small number of participants. Might look at what the maximum tolerated dose is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens in Phase 2 Trials

A

Does it have the potential to be beneficial to patients. Make a stop-go decision.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What happens in Phase 3 Trials

A

A randomised, large, comparative trial. Confirmatory. Confirms effectiveness within a population.

17
Q

What is efficacy

A

Treatment effect produced under ideal conditions

18
Q

What is effectiveness

A

Treatment effect that would be produced in real clinical practice

19
Q

When is an explanatory approach typically taken

A

Earlier stage trials

20
Q

What is the sample like in an explanatory trial

A

Carefully defined patients in a research clinic

21
Q

What is the sample like in a pragmatic trial

A

Reflects variation between treatments that occurs in real clinical practice in order to reduce the chance of over-estimating treatment effect,

22
Q

What are the outcomes in an explanatory trial usually

A

Biological

23
Q

What are the outcomes in a pragmatic trial usually

A

Broad health effects

24
Q

What is the aim of an explanatory trial

A

Further scientific knowledge

25
Q

What is the aim of a pragmatic trial

A

Inform choice of treatment for a patient

26
Q

Is per-protocol explanatory or pragmatic

A

Explanatory

27
Q

Is intention to treat explanatory or pragmatic

A

Pragmatic

28
Q

What does the intention to treatment analysis population consist of

A

All randomised patients in analysis regardless of anything that happens after randomisation.